Category: BIOTECHNOLOGY

On Thursday, Pfizer Inc. (NYSE:PFE)’s shares inclined 0.03% to $34.15. PFE has beta value of 0.90. The company has the market capitalization of $210.55 billion. Return on assets ratio of the company was 5.40% while its return on equity ratio...

On Thursday, Gilead Sciences, Inc. (NASDAQ:GILD)’s shares declined -1.06% to $107.83. GILD has beta value of 0.83. The company has the market capitalization of $159.94 billion. Return on assets ratio of the company was 42.70% while its return on equity.....

On Thursday, Celgene Corporation (NASDAQ:CELG)’s shares declined -5.28% to $120.46. CELG offered 23.60% EPS for prior five years. The company has 34.60% return on equity value while its ROI ratio was 16.30%. The company has $100.53 billion market capital...

On Thursday, Shares of Kindred Healthcare, Inc (NYSE:KND), lost -18.94% to $11.81. KND, latest closing price of $11.81 is at a discount to its 200-day moving average price of $19.89. Its 52-week range has been $11.15 - $24.66; it is...

On Wednesday, Merck & Co., Inc. (NYSE:MRK)’s shares inclined 0.80% to $55.54. MRK offered -6.30% EPS for prior five years. The company has 21.00% return on equity value while its ROI ratio was 0.50%. The company has $155.25 billion market...

On Wednesday, BioScrip Inc (NASDAQ:BIOS)’s shares inclined 26.42% to $2.68. BIOS is currently valued at $145.71 million. The company has 68.73 million shares outstanding and 80.10% shares of the company were owned by institutional investors. The company ...

On Wednesday, Zoetis Inc (NYSE:ZTS)’s shares declined -0.17% to $46.55. ZTS is currently valued at $23.27 billion. The company has 499.34 million shares outstanding and 93.50% shares of the company were owned by institutional investors. The company has 4...

On Wednesday, Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s shares inclined 7.59% to $9.50. FOLD is currently valued at $1.05 billion. The company has 118.62 million shares outstanding and 97.60% shares of the company were owned by institutional investors. T...

On Wednesday, Boston Scientific Corporation (NYSE:BSX)’s shares declined -0.05% to $18.67. BSX has market value of $25.09 billion while its EPS was booked as $-0.30 in the last 12 months. The stock has 1.34 billion shares outstanding while 91.90% shares....